# Radiofrequency Ablation of Lung Tumors

> **NCT00180856** · PHASE2 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 60 (—)

## Conditions studied

- Lung Cancer
- Metastasis

## Interventions

- **PROCEDURE:** Radiofrequency ablation

## Key facts

- **NCT ID:** NCT00180856
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2005-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00180856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00180856, "Radiofrequency Ablation of Lung Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00180856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*